Legacy Pharmaceutical Packaging recalls
Legacy Pharmaceutical Packaging has 12 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 3 Jan 2024. 5 are still ongoing. The most frequent reason is packaging defects.
Total recalls 12 since 2013
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 5 latest 3 Jan 2024
Recalls per month, last 24 months click a bar for that month Severity split
0 0%10 83%2 17%
Why legacy pharmaceutical packaging is recalled
Ongoing legacy pharmaceutical packaging recalls 5 active Reported Class Recall Company Reason Where 3 Jan 2024 Drug CLASS II Sertraline Tablets, USP 100 mg recalled by Legacy Pharmaceutical Sertraline Hydrochloride Legacy Pharmaceutical Packaging Manufacturing (CGMP) Deviations AR, CA 8 May 2019 Drug CLASS II Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity AZ, TN 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 25 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 100 mg recalled Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states
All legacy pharmaceutical packaging recalls, newest first 12 total Reported Class Recall Company Reason Where 3 Jan 2024 Drug CLASS II Sertraline Tablets, USP 100 mg recalled by Legacy Pharmaceutical Sertraline Hydrochloride Legacy Pharmaceutical Packaging Manufacturing (CGMP) Deviations AR, CA 7 Oct 2020 Drug CLASS III Metformin Hydrochloride Tablets USP, 1000 mg recalled Legacy Pharmaceutical Packaging Packaging Defects AR, GA 8 May 2019 Drug CLASS II Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity AZ, TN 10 Apr 2019 Drug CLASS II Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity AZ, IN, TN 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 25 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states 27 Mar 2019 Drug CLASS II Losartan Potassium Tablets, USP, 100 mg recalled Legacy Pharmaceutical Packaging Nitrosamine Impurity 5 states 29 Mar 2017 Drug CLASS II Atenolol Tablets, USP, 50 mg recalled by Legacy Pharmaceutical Legacy Pharmaceutical Packaging Packaging Defects Nationwide 18 Jun 2014 Drug CLASS II Pantoprazole Sodium, Delayed-release tablets, USP dose packages recalled Legacy Pharmaceutical Packaging Packaging Defects IN 7 May 2014 Drug CLASS II Fluoxetine Capsules, USP, 20 mg recalled by Legacy Pharmaceutical Fluoxetine Legacy Pharmaceutical Packaging Packaging Defects Nationwide 12 Jun 2013 Drug CLASS III Lorazepam, 0.5 mg tablets, 100 count, RX only recalled Legacy Pharmaceutical Packaging Other IN 22 May 2013 Drug CLASS II Walmart Amlodipine Besylate Tablets, USP 10 mg recalled Legacy Pharmaceutical Packaging Packaging Defects Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.